Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 19, 2018 03:59 ET | Source: InSphero AG

InSphero and Path BioAnalytics Announce Partnership to Develop Advanced 3D Airway Tissue Model for Cystic Fibrosis Research

Schlieren, Switzerland, Dec. 19, 2018 (GLOBE NEWSWIRE) -- InSphero AG and Path BioAnalytics today announced a partnership through which Path BioAnalytics will produce and test 3D cystic fibrosis...
November 29, 2018 08:00 ET | Source: InSphero AG

AstraZeneca Relies on 3D InSight™ Human Islet Microtissues in Pancreatic Beta-cell Study

Schlieren, Switzerland, Nov. 29, 2018 (GLOBE NEWSWIRE) -- In a recent study published in ScienceAdvances, researchers in the Innovative Medicines and Early Development (IMED) Biotech Unit of...
October 11, 2018 00:37 ET | Source: InSphero AG

InSphero achieves new milestone with Akura™ Flow organ-on-a-chip technology in low-clearance drug study

Schlieren, Switzerland, Oct. 11, 2018 (GLOBE NEWSWIRE) -- InSphero AG today announced that it has successfully completed a collaborative project with the FHNW University in Switzerland to develop a...
June 13, 2018 02:00 ET | Source: InSphero AG

InSphero Receives Additional USD 10m for Organ-on-a-Chip Disease Models

Schlieren, Switzerland, June 13, 2018 (GLOBE NEWSWIRE) -- InSphero AG today announced that it has raised USD 10 million in its latest funding round with additional financing, secured from internal...
June 11, 2018 09:00 ET | Source: InSphero AG

InSphero Partners with ALPCO to Advance Diabetes Research

Schlieren, Switzerland, June 11, 2018 (GLOBE NEWSWIRE) -- InSphero AG, the leading provider of 3D cell-based platforms for preclinical drug safety and efficacy testing, today announced that it is...
October 26, 2017 08:00 ET | Source: InSphero AG

InSphero and Charles River Announce PDX Partnership

Schlieren, Switzerland, Oct. 26, 2017 (GLOBE NEWSWIRE) -- InSphero AG and Charles River Laboratories International, Inc. today announced a partnership through which Charles River will license its...
October 18, 2017 08:00 ET | Source: InSphero AG

InSphero to Present Novel 3D Human Liver Fibrosis Model at Annual Liver Meeting® in Washington, DC

Schlieren, Switzerland, Oct. 18, 2017 (GLOBE NEWSWIRE) -- InSphero AG, the leading supplier of assay-ready 3D cell culture models for accelerating drug discovery and development, will present data...
June 29, 2017 08:00 ET | Source: InSphero AG

Comprehensive Study by AstraZeneca and Genentech Confirms Superiority of InSphero Human Liver Microtissues for Prediction of Drug-Induced Liver Injury

Schlieren, Switzerland, June 29, 2017 (GLOBE NEWSWIRE) -- In the most comprehensive evaluation of 3D spheroid hepatic cultures conducted to date, a publication co-authored by lead toxicologists and...